Dr Juanita Lopez is a Consultant Medical Oncologist at the Phase I Drug Development Unit at the Royal Marsden and the Institute of Cancer Research, specialising in early phase translational drug development and the treatment of patients with brain tumours.
Dr Lopez graduated from the University of Cambridge with a double first class in 2001 obtaining numerous prizes and completing an intercalated laboratory research year in development neurosciences. She then completed her general medical training in London, and was awarded the MRCP in 2004. She was awarded a four year Clinical Research Training Fellowship from Avon-Breakthrough Breast Cancer to carry out laboratory research at the ICR, which led to the award of a PhD.
Her main research interests lie in understanding the interplay between inflammation, immune-responses and cancer, and rationally developing novel treatments and combinations. She has served as UKCI for a number of early phase clinical trials including first-in-human trials, as well as several for brain tumours.